Pop up

약학대학-약대소개

성명	유기연
직급	부교수
학위	PharmD, PhD
세부전공	임상약학
TEL	02-940-4519
E-mail	kiyon@dongduk.ac.kr

학력 및 경력	학력 및 경력	연구분야	연구분야	학술논문	학술논문	저서 및 특허	저서 및 특허

연구수행실적

Principle Investigator

1. Development of a predictive model for anemia of chronic disease in atopic disease patients using real-world data; Funded by National Research Foundation of Korea (06/2021-02/2024)

2. Analysis of Risk Factors for QT Prolongation on the Domperidone Prescriptions; Funded by National Research Foundation of Korea (09/2017-08/2020)

3. Study on International Harmonization Plan Including Domestic Drug Related Regulation; Funded by Ministry of Food and Drug Safety (02/2017-11/2017)

4. A Study on the Establishment and Operation of Drug Safety Management System for Korea Reunification Period; Funded by Ministry of Food and Drug Safety (02/2017-07/2017)

5. Development and Validation of a Prediction Model for Adverse Drug Reactions Based on Statistical Analysis of Case Reports; Funded by Ministry of Food and Drug Safety (03/2016-11/2016)

6. Database Construction for Herbal Medicine Induced Hypoglycemia and Diabetic Complications; Funded by Korean Institute of Oriental Medicine (06/2013-12/2013)

7. Analysis of Effect of CyP450 Enzyme of Korean Medicine; Funded by Korean Institute of Oriental Medicine (01/2012-12/2012)

8. Clinical Analysis Test for Prevention of Diabetic or Diabetic Vascular Complications of Purpura; Funded by Korean Institute of Oriental Medicine (01/2012-09/2012)

9. Analysis of Drug-Drug Interaction between Korean and Western Medicine; Funded by Korean Institute of Oriental Medicine (09/2011-12/2011)

Co-researcher

1. Develop Appropriate Information on Drug Utilization Review; Funded by Ministry of Food and Drug Safety (08/2017-02/2018)

2. Development of Textbooks for Safe Use of Medicines by Life Cycle; Funded by Ministry of Food and Drug Safety (02/2017-11/2017)

3. Development of Guideline for screening medical device sterilization disinfectant; Funded by Ministry of Food and Drug Safety (03/2016-11/2016)

4. Improvement of pharmacy service for drug vulnerable classes; Funded by Korea Health Industry Development Institute (03/2014-11/2014)

5. Development of Pharmaceutical Service Model for Chronic /Metabolic Patients; Funded for by Korea Health Industry Development Institute (07/2013-06/2016)

6. Development of comprehensive drug information collection for safe use of medicines; Funded by Ministry of Food and Drug Safety (02/2010-11/2011)

7. Study on the Efficacy and Safety of Medication in Off-labeled Use: Anti-pathogenic Drug; Funded by Ministry of Food and Drug Safety (08/2011-11/2011)

학술논문

1. Rhew K*, Choi J, Kim K, Choi KH, Lee SH, Park HW. Increased Risk of Anemia in Patients with Asthma. Clin Epidemiol. 2023;15:31-38.

2. Rhew K, Chae YJ, Chang JE. Progress and recent trends in photodynamic therapy with nanoparticles. J Pharm Investig. 2022; 52:587？599.

3. Rhew K*. Medication Prescribing Status in Pediatric Patients with Migraine. Kor J Clin Pharm. 2022;32(3):178-184.

4. Kim J, Lee S, Rhew K*. Association between Gastrointestinal Diseases and Migraine. Int J Environ Res Public Health. 2022;19(7):4018.

5. Jang IW, Chang JE, Kim J, Rhew K*. Status of Medications Prescribed for Psychiatric Disorders in Korean Pediatric and Adolescent Patients. Children (Basel). 2022;9(1):68.

6. Lee M, Kim K, Rhew K, Choi KH. A Knowledge, Attitude, and Practice Survey on Medication Safety in Korean Older Adults: An Analysis of an Ageing Society. Healthcare (Basel). 2021 Oct 14;9(10):1365.

7. Chang JE, Lee HM, Kim J, Rhew K*. Prevalence of Anemia in Pediatric Patients According to Asthma Control: Propensity Score Analysis. J Asthma Allergy. 2021;14:743-751.

8. Song HJ, Rhew K, Lee YJ, Ha IH. Acid-suppressive agents and survival outcomes in patients with cancer: a systematic review and meta-analysis. Int J Clin Oncol. 2021 Jan;26(1):34-50.

9. Lee H, Kim J, Rhew K*. The Association between Medication Use for Dyslipidemia and Osteoporosis. Kor J Clin Pharm. 2021;31(4):278-284.

10. Kim JY, Rhew K*. Atherosclerotic Cardiovascular Disease Risk and Statin Prescription Status in Korean Adult Patients. Kor J Clin Pharm. 2021;31(3):198-204.

11. Rhew K, Han N, Goodin AJ, Oh JM. Domperidone prescribing patterns in pediatric patients before and after safety warning in South Korea. Int J Clin Pharmacol Ther. 2020;58:687-695.

12. Rhew K, Brown J, Oh JM. Atopic Disease and Anemia in Korean Patients: Cross-Sectional Study with Propensity Score Analysis. Int J Environ Res Public Health. 2020;17(6):1978.

13. Yun D, Chang J, Rhew K*. Analysis of Prevalence of Anemia according to Severity of Atopic Dermatitis. Kor J Clin Pharm. 2020;30:264-269.

14. Yoon SM, Lee S, Chang J, Lee YS, Rhew K*. The Prescribing Patterns of Antipsychotic Drugs and Antiparkinsonian Drugs in Elderly Patients with Dementia. Kor J Clin Pharm. 2020;30:81-86.

15. Rhew K, Han N, Oh JM. Impact of Safety Warning on Domperidone Prescribing for Geriatric Patients in South Korea: Analysis of National Insurance Claim Data. Int J Environ Res Public Health. 2019;16:2985.

16. Tran PT, Winterstein AG, Wang X, Rhew K, Antonelli PJ. Appropriateness of Otic Quinolone Use among Privately Insured US Patients. Otolaryngol Head Neck Surg. 2020;162:102-107.

17. Rhew K, Oh JM. Association between atopic disease and anemia in pediatrics: a cross-sectional study. BMC Pediatr. 2019;19(1):455.

18. Rhew K*. The Risk of Cardiovascular Disease and Diabetes in Rheumatoid Arthritis Patients: A Propensity Score Analysis. Kor J Clin Pharm. 2019;29:109-114.

19. Rhew K*, Reams VZ, Brown JD, Winterstein AG. Commentary on: Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence. Ann Med. 2019;51:97-98.

20. Han N, Han SH, Chu H, Kim J, Rhew KY, Yoon JH, Je NK, Rhie SJ, Ji EH, Lee E, Kim YS, Oh JM. Service design oriented multidisciplinary collaborative team care service model development for resolving drug related problems. PLoS One. 2018 Sep 28;13(9):e0201705.

21. Jung SH, Choi KH, Kwon KH, Rhew K*. Analysis of the Influence of Holding Pharmacist Specialization for Professionalism and Job Satisfaction. J. Kor. Soc. Health-syst. Pharm. 2018;35:441-452.

22. Moon SJ, Lee YS, Rhew K*. Analysis of the Use of Medical Institutions and Prescription Drugs for Pulmonary Tuberculosis in Geriatric Patients. Kor J Clin Pharm. 2018;28:221-227.

23. Rhew K, Kang J, Oh JM, Han N, Lee IH, Je NK, Ji E, Lee E, Yoon JH, Rhie SJ. Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea. Patient Prefer Adherence. 2017;11:1381-1388.

24. Rhew K, Han N, Cho KT, Yoon JH, Oh JM. Prioritization of diseases for the development of a pharmaceutical care service model in South Korea using the analytic hierarchy process. Int J Clin Pharmacol Ther. 2017;55(11):866-874.

25. Kim HH, Rhew K*. Analysis of Adverse Drug Reaction Reports Using Text Mining. Kor J Clin Pharm. 2017;27:221-227.

26. Rhew K*. Analysis of Cardiovascular Medication Use in Dementia Patients. Kor J Clin Pharm. 2017;27(3):136-142.

27. Jeong S, Han N, Choi B, Sohn M, Song YK, Chung MW, Na HS, Ji E, Kim H, Rhew KY, Kim T, Kim IW, Oh JM. Construction of a database for published phase II/III drug intervention clinical trials for the period 2009-2014 comprising 2,326 records, 90 disease categories, and 939 drug entities. Int J Clin Pharmacol Ther. 2016;54(6):416-25.

28. Lee IH, Rhie SJ, Je NK, Rhew KY, Ji E, Oh JM, Lee E, Yoon JH. Perceived needs of pharmaceutical care services among healthcare professionals in South Korea: a qualitative study. Int J Clin Pharm. 2016;38(5):1219-29.

29. Oh EK, Rhew KY*. Evaluation of Azithromycin Prescriptions for Pediatric Patients. Kor J Clin Pharm. 2016;26(2):115-120.

30. Choi EJ, Song IJ, Yoon H, Rhew KY*. Tosufloxacin Tosylate Increased the Liver Enzyme Levels in a Bladder Cancer Patient with Normal Liver Functions: a Case Report Kor J Clin Pharm. 2015;25(1):56-58.

31. Kim JY, Kim JS, Jung JH, Chun P, Rhew KY*. Inhibitory effects of Puerarin on cytochrome P450 subfamilies in vitro. Orient Pharm Exp Med. 2014: 14(1):1-5.

32. Kim JY, Nakagawa N, Yoon H, Chun P, Rhew KY*. Effect of SLCO1B1*15 on Pravastatin Pharmacokinetics: A Systematic Review and Meta-analysis. Kor J Clin Pharm. 2014: 24(4): 239-247.

33. Kim JY, Kim JS, Chung JH, Kim JT, Yoon HO, Rhew KY*. Effectiveness of Herbal Medicines Containing Kudzu Root as a Principal Ingredient in Patients with Diabetes Mellitus. Kor Soc Health-Syst Pharm. 2014: 31(6):1074-1083.

34. Yoon SM, Kim JY, Kim JT, Rhew KY*. Effect of Problem Based Learning Application in Institutional Pharmacy Practice Course for College of Pharmacy Students. Kor Soc Health-Syst Pharm. 2014: 31(2):735-43.

35. Chun P, Kim JY, Kim JT, Koo BK, Rhew KY*. Review of Herbal Interactions with Antiplatelet Drugs. Kor Soc Health-Syst Pharm. 2014: 31(2):691-704.

36. Yoon H, Rhew KY. Famciclovir as an Antiviral Agent for a Patient with Acute Renal Failure..Int J Clin Pharm. 2013: 35(2): 173-175.

37. Han Y, Rhew KY. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity. Int Immunopharmacol. 2013; 17(3): 651-657.

38. Kim JT, Kim JY, Kim MC, Rhew KY*. Assessment of Problem Based Learning Application in Clinical Pharmacy Education. Kor J Clin Pharm. 2013: 23(1): 65-70.

39. Rhew KY*. The Effect of Treatment for Chronic Myeloid Leukemia: Meta- Analysis J. Kor Soc Health-Syst Pharm. 2013: 30(4):304-319.

40. Jung JH, Kim KT, Rhew KY *. Assessment of Pediatric Adverse Drug Reaction Reports. Kor Soc Health-Syst Pharm. 2013: 30(2):108-118.

41. Rhew KY *. Drug Safety Perception and Medication Adherence in Pregnancy. Kor J Clin Pharm. 2013: 23(3): 197-205.

42. Chun P, Kim JY, Kim JT, Koo BK, Rhew KY*. A Review of Herbal Interactions with Warfarin. Kor Soc Health-Syst Pharm. 2013: 30(5): 450-470.

43. Han Y, Rhew KY. The Regulatory Mechanism of 4-Phenylbutyric Acid against ER Stress Induced Autophagy in Human Gingival Fibroblasts. Arch Pharm Res. 2012: 7: 1269-1278.

44. Rhew KY, Cho HK, Lee S. Characteristics of Cardiovascular Adverse Drug Reactions Reported to KFDA. Kor J Clin Pharm. 2012: 22; 441-460.

45. Kim JY, Lee S, Rhew KY*. Meta-analysis of the Efficacy of Infliximab in Patients with Moderate-severe Ulcerative Colitis. Kor J Clin Pharm. 2012: 22; 251-259.

46. Yang SH, Lee TR, Lee S, Rhew KY*. Analysis on the Statistical Methods and Errors in Articles of Korean Journal of Clinical Pharmacy. Kor Soc Health-Syst Pharm. 2012: 37; 1-11.

47. Li B, Kim DS, Oh HW, Lim HD, Lee W, Rhew KY, Kim H. N-Nitrosodimethylamine induced lung fibroblast cell death is associated with JNK activation. Molecular & Cellular Toxicology. 2012: 8; 155-161.

48. Rhew KY, Lee S. Analysis of the Korea Food and Drug Administration Adverse Drug Reaction Reports. Kor J Clin Pharm. 2011; 21(2): 138-144.

49. Rhew KY*. Comparative Study on the Two Different Doses of Dexrazoxane. Kor J Clin Pharm. 2010; 20(4): 248-254.

닫기